Topical Methyl Aminolevulinate: A Viewpoint by Lasse R. Braathen

ISSN： 1175-0561

Source： American Journal of Clinical Dermatology, Vol.5, Iss.2, 2004-01, pp. : 138-140

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Topical Methyl Aminolevulinate

By M. Asif A. Siddiqui Caroline M. Perry Lesley J. Scott

American Journal of Clinical Dermatology, Vol. 5, Iss. 2, 2004-01 ,pp. : 127-137

Adis International

Access to resources Recommend Favorite

Topical Aminolevulinic Acid HCl: A Viewpoint by Edward Jeffes III

By Jeffes E.I.

American Journal of Clinical Dermatology, Vol. 1, Iss. 2, 2000-03 ,pp. : 140-141

Adis International

Access to resources Recommend Favorite

Adjuvanted Influenza Vaccine: A Viewpoint by R. Baltussen

By Baltussen R.

BioDrugs, Vol. 14, Iss. 1, 2000-07 ,pp. : 70-71

Adis International

Access to resources Recommend Favorite

Hexyl Aminolevulinate in the Detection of Bladder Cancer: Profile Report

By Frampton James E. Plosker Greg L.

BioDrugs, Vol. 20, Iss. 5, 2006-01 ,pp. : 317-320

Adis International

Access to resources Recommend Favorite

Topical Eflornithine

By Barman Balfour J.A. McClellan K.

American Journal of Clinical Dermatology, Vol. 2, Iss. 3, 2001-03 ,pp. : 197-201

Adis International

Access to resources Recommend Favorite